BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22144431)

  • 1. Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.
    Eyase FL; Akala HM; Johnson JD; Walsh DS
    Am J Trop Med Hyg; 2011 Dec; 85(6):984-8. PubMed ID: 22144431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
    Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
    Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
    Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
    PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar.
    Juliano JJ; Randrianarivelojosia M; Ramarosandratana B; Ariey F; Mwapasa V; Meshnick SR
    Malar J; 2009 Mar; 8():47. PubMed ID: 19291288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China.
    Lu F; Zhang M; Culleton RL; Xu S; Tang J; Zhou H; Zhu G; Gu Y; Zhang C; Liu Y; Wang W; Cao Y; Li J; He X; Cao J; Gao Q
    Parasit Vectors; 2017 Jul; 10(1):355. PubMed ID: 28747223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia.
    Mulenga MC; Sitali L; Ciubotariu II; Hawela MB; Hamainza B; Chipeta J; Mharakurwa S
    Malar J; 2021 Jul; 20(1):329. PubMed ID: 34320992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13 years after cessation of chloroquine use in Msambweni, Kenya.
    Kiarie WC; Wangai L; Agola E; Kimani FT; Hungu C
    Malar J; 2015 Aug; 14():328. PubMed ID: 26296743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine.
    Huang B; Wang Q; Deng C; Wang J; Yang T; Huang S; Su XZ; Liu Y; Pan L; Li G; Li D; Zhang H; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zheng S; Xu Q; Lu F; Guan Y; Song J
    Malar J; 2016 Aug; 15(1):414. PubMed ID: 27527604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in Pfcrt and Pfmdr-1 genes after five years withdrawal of chloroquine for the treatment of Plasmodium falciparum malaria in West Bengal, India.
    Chatterjee M; Ganguly S; Saha P; Guha SK; Basu N; Bera DK; Maji AK
    Infect Genet Evol; 2016 Oct; 44():281-285. PubMed ID: 27448953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The return of chloroquine-sensitive Plasmodium falciparum parasites in Jazan region, southwestern Saudi Arabia over a decade after the adoption of artemisinin-based combination therapy: analysis of genetic mutations in the pfcrt gene.
    Madkhali AM; Abdulhaq AA; Atroosh WM; Ghzwani AH; Zain KA; Ghailan KY; Hamali HA; Mobarki AA; Eisa ZM; Lau YL; Al-Mekhlafi HM
    Parasitol Res; 2021 Nov; 120(11):3771-3781. PubMed ID: 34561749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
    Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
    Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine resistance before and after its withdrawal in Kenya.
    Mwai L; Ochong E; Abdirahman A; Kiara SM; Ward S; Kokwaro G; Sasi P; Marsh K; Borrmann S; Mackinnon M; Nzila A
    Malar J; 2009 May; 8():106. PubMed ID: 19450282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.
    Ly O; Gueye PE; Deme AB; Dieng T; Badiane AS; Ahouidi AD; Diallo M; Bei AK; Wirth DF; Mboup S; Sarr O
    Parasitol Res; 2012 Oct; 111(4):1541-6. PubMed ID: 22706959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of chloroquine and sequence variation in pfcrt gene among patients with falciparum malaria in central India.
    Bharti PK; Alam MT; Boxer R; Shukla MM; Gautam SP; Sharma YD; Singh N
    Trop Med Int Health; 2010 Jan; 15(1):33-40. PubMed ID: 19912592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of chloroquine-resistant mutations in the Plasmodium falciparum pfcrt and pfmdr-1 genes in Hadhramout, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Acta Trop; 2015 Sep; 149():59-63. PubMed ID: 26001972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of chloroquine plus primaquine treatment and pfcrt mutation in uncomplicated falciparum malaria patients in Rangamati, Bangladesh.
    Kawai A; Arita N; Matsumoto Y; Kawabata M; Chowdhury MS; Saito-Ito A
    Parasitol Int; 2011 Dec; 60(4):341-6. PubMed ID: 21645634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimalarial ferroquine: from bench to clinic.
    Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
    Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.